Dexamethasone destabilizes Nmyc to inhibit the growth of hedgehog-associated medulloblastoma.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 20530674.
- Also identified by DOI 10.1158/0008-5472.CAN-10-0554 and PMC identifier 2896447.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mouse studies indicate that the synthetic glucocorticoid dexamethasone (Dex) impairs the proliferation of granule neuron precursors in the cerebellum, which are transformed to medulloblastoma by activation of Sonic hedgehog (Shh) signaling. Here, we show that Dex treatment also inhibits Shh-induced tumor growth, enhancing the survival of tumor-prone transgenic mice. We found that Nmyc was specifically required in granule cells for Shh-induced tumorigenesis and that Dex acted to reduce Nmyc protein levels. Moreover, we found that Dex-induced destabilization of Nmyc is mediated by activation of glycogen synthase kinase 3beta, which targets Nmyc for proteasomal degradation. Together, our findings show that Dex antagonizes Shh signaling downstream of Smoothened in medulloblastoma.
Medical subject headings
- Brain Neoplasms
- Dexamethasone
- Hedgehog Proteins
- Medulloblastoma
- Proto-Oncogene Proteins c-myc